Compare KEQU & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KEQU | STXS |
|---|---|---|
| Founded | 1906 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.6M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | KEQU | STXS |
|---|---|---|
| Price | $39.00 | $2.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 7.4K | ★ 407.2K |
| Earning Date | 12-10-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.94 | N/A |
| Revenue | ★ $285,515,000.00 | $30,075,000.00 |
| Revenue This Year | N/A | $24.48 |
| Revenue Next Year | N/A | $29.98 |
| P/E Ratio | $9.72 | ★ N/A |
| Revenue Growth | ★ 43.02 | 19.62 |
| 52 Week Low | $30.33 | $1.54 |
| 52 Week High | $71.33 | $3.59 |
| Indicator | KEQU | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 44.42 | 42.80 |
| Support Level | $37.50 | $2.31 |
| Resistance Level | $39.53 | $2.42 |
| Average True Range (ATR) | 1.33 | 0.09 |
| MACD | 0.17 | 0.01 |
| Stochastic Oscillator | 36.68 | 44.35 |
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.